Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MYL12A Antikörper (N-Term)

Rockland 100-401-416 MYL12A Reaktivität: Human WB, IHC, ELISA, IP Wirt: Kaninchen Polyclonal unconjugated
Rockland
Produktnummer ABIN5596872
Hersteller Produkt- Nr.: 100-401-416
  • Target Alle MYL12A Antikörper anzeigen
    MYL12A (Myosin, Light Chain 12A, Regulatory, Non-Sarcomeric (MYL12A))
    Bindungsspezifität
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 10
    • 5
    • 4
    • 1
    • 1
    Human
    Wirt
    • 12
    Kaninchen
    Klonalität
    • 12
    Polyklonal
    Konjugat
    • 12
    Dieser MYL12A Antikörper ist unkonjugiert
    Applikation
    • 11
    • 8
    • 7
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunoprecipitation (IP)
    Hersteller Produkt- Nr.
    100-401-416
    Hersteller
    Rockland
    Verwendungszweck
    Myosin phospho S19/phospho S20 Antibody
    Kreuzreaktivität (Details)
    This antiserum is phosphospecific and detects monophosphorylated and diphosphorylated forms of the protein.
    Produktmerkmale
    Synonyms: rabbit anti-Myosin pS19/pS20 Antibody, Myosin regulatory light chain 12A, Myosin regulatory light chain MRLC3, Myosin regulatory light chain 2, nonsarcomeric, Myosin RLC, MLC-2B
    Aufreinigung
    Anti-Myosin pS19/pS20 antibody is directed against the regulatory light chain of smooth and non-muscle myosin.
    Sterilität
    Sterile filtered
    Immunogen

    Immunogen: Human Myosin Light Chain phospho peptide corresponding to a region near the amino terminus of the human smooth/non-muscle form of myosin regulatory light chain conjugated to Keyhole Limpet Hemocyanin (KLH).

    Immunogen Type: Conjugated Peptide

    Top Product
    Discover our top product MYL12A Primärantikörper
  • Applikationshinweise

    Immunohistochemistry Dilution: 2.5 μg/mL

    Application Note: Anti-Myosin pS19/pS20 phospho specific polyclonal antibody was tested by ELISA and immunoblotting.   Immunoblotting was used to show reactivity with unstimulated and stimulated cardiac myocytes.  The antibody was also reactive with the phosphorylated form of the immunizing peptide and minimally reactive with the non-phosphorylated form of the immunizing peptide.  Although not tested, this antibody is likely functional by immunohistochemistry and immunoprecipitation.

    Western Blot Dilution: 1:1,000 - 1:5,000

    Immunoprecipitation Dilution: 1:100

    ELISA Dilution: 1:5,000 - 1:20,000

    Other: User Optimized

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    70 mg/mL
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
    Haltbarkeit
    12 months
  • Target
    MYL12A (Myosin, Light Chain 12A, Regulatory, Non-Sarcomeric (MYL12A))
    Andere Bezeichnung
    MYL12A (MYL12A Produkte)
    Hintergrund
    Background: Myosin is the major component of thick muscle filaments, and is a long asymmetric molecule containing a globular head and a long tail.  The molecule consists of two heavy chains each ~200,000 daltons, and four light chains each ~16,000 - 21,000 daltons.  Activation of smooth and cardiac muscle primarily involves pathways that increase calcium levels and myosin phosphorylation, resulting in contraction.   Myosin light chain phosphatase acts to regulate muscle contraction by dephosphorylating activated myosin light chain.  This antibody is specific for the phosphorylated form of myosin light chain.  The selected peptide sequence used to generate the polyclonal antibody is located near the amino terminal end of the polypeptide corresponding to the smooth/non-muscle form of myosin regulatory light chain found in cardiac myocytes in addition to smooth and non-muscle cells.  This sequence differs from that of the sarcomeric/cardiac form of myosin regulatory light chain that has a different sequence around the phosphorylation site.  Human and mouse have almost identical sequences.  In human the phosphorylation site is pS19, while in mouse the site maps to pS20.
    Gen-ID
    10627
    UniProt
    P19105
Sie sind hier:
Kundenservice